Metlife Inc(MET) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 18.31 | EPS (ttm) | 5.23 | Insider Own | 16.17% | Shs Outstand | 637.8M | Perf Week | 1.35% |
| Market Cap | 60.81B | Forward P/E | 8.61 | EPS next Y | 10.89% | Insider Trans | -0.02% | Shs Float | 532.7M | Perf Month | -1.38% |
| Enterprise Value | - | PEG | 0.72 | EPS next Q | 2.56 | Inst Own | 79.45% | Short Float | 2.12% | Perf Quarter | 11.83% |
| Income | 3.44B | P/S | 0.76 | EPS this Y | 13.56% | Inst Trans | -1.04% | Short Ratio | 3.11 | Perf Half Y | 35.54% |
| Sales | 79.56B | P/B | 2.22 | EPS next 5Y | 12.02% | ROA | 0.5% | Short Interest | 11.31M | Perf YTD | 21.22% |
| Book/sh | 43.03 | P/C | - | EPS past 3/5Y | -9.24% -3.68% | ROE | 13.16% | 52W High | -5.19% ($100.93) | Perf Year | 20.68% |
| Cash/sh | - | P/FCF | 3.67 | Sales past 3/5Y | 3.88% 2.59% | ROIC | 7.46% | 52W Low | 42.12% ($67.33) | Perf 3Y | 51.15% |
| Dividend Est. | $2.35 (2.45%) | EV/EBITDA | - | EPS Y/Y TTM | -11.62% | Gross Margin | - | Volatility(W/M) | 2.12% 1.64% | Perf 5Y | 56.79% |
| Dividend TTM | 2.32 | EV/Sales | - | Sales Y/Y TTM | 8.96% | Oper. Margin | 7.69% | ATR (14) | 1.87 | Perf 10Y | 144.54% |
| Dividend Ex-Date | 2026/8/4 | Quick Ratio | - | EPS Q/Q | 5.39% | Profit Margin | 4.33% | RSI (14) | 49.77 | Recom | 1.95 |
| Dividend Gr. 3/5Y | 4.35% 4.33% | Current Ratio | 4.83 | Sales Q/Q | 11.37% | SMA20 | -0.51% ($96.18) | Beta | 0.77 | Target Price | $106.47 |
| Payout | 47.69% | Debt/Eq | 0.79 | Earnings | 2026/8/5 | SMA50 | 1.02% ($94.72) | Rel Volume | 0.88 | Prev Close | $95.5 |
| Employees | 46000 | LT Debt/Eq | 0.77 | EPS/Sales Surpr. | 5.87% -3% | SMA200 | 16.47% ($82.16) | Avg Volume(3M) | 3.64M | Price | $95.69 |
| IPO | 2000/4/5 | Option/Short | Yes/Yes | Trades | 28192 | Volume | 3,220,206 | Change | 0.2% |
Company
MET is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🛡️ MetLife (MET) is a leading global life insurance, annuity, and employee benefits company headquartered in the United States, founded in 1868. It operates across a wide range of global markets, including the U.S., Asia, Latin America, Europe, and the Middle East, with a key characteristic being its diversified business structure built on four pillars: Group Insurance, Annuities, International Business, and Asset Management.
Over the past 1 year, on the higher side
5% below its 1-year high.
MET has weak earning power
7.69% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +13.6% this year.
Tap to view numbers
The price looks about right
Trading at 18.3 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +51.1% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 2.45% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 79.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SHRY 0.05%
IAK 0.04%
PZLV 0.03%
PJFV 0.03%
PFFV 0.03%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
IAU 65.2B
SGOL 7.5B
XME 4.9B
SIVR 4.6B
GLTR 2.8BIt ranks #2 in the industry
Based on market cap of $61B.
MET $61B PER 18.3
MFC $71B PER 16.0
AFL $58B PER 12.3
PRU $41B PER 10.7
FAQ
What kind of company is MET?
MET belongs to the Financial sector and operates in the Insurance - Life industry.
What is the market cap of MET?
The market cap of MET is approximately $60.8B, ranking 280 within its sector.
Does MET pay dividends?
MET has a dividend yield of approximately 2.45%, with an annual dividend of $2.35.
What is the P/E ratio of MET?
MET has a P/E ratio of approximately 18.3x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for MET?
MET has recorded a 52-week high of $100.93 and a low of $67.33.
